Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page
- Check5 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study details, replacing content with a generic error page. This blocks access to the NCT03608358 record and its information.SummaryDifference20%

- Check26 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new version of the record. This reflects internal versioning rather than substantive changes to the study data or presentation.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing Revision: v3.6.5, indicating a small version update to the page's template or content.SummaryDifference0.1%

- Check62 days agoChange DetectedAdds Type 2 diabetes as a study topic and MedlinePlus Genetics as a related topic, with the page revision updated to v3.6.5. Removes the sponsor AstraZeneca and certain external links (Clinical Study Results on trialsummaries.com and Helpful Links Provided by) along with the older revision tag v3.6.4.SummaryDifference0.4%

- Check83 days agoChange DetectedThe page footer displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a minor release or template update applied to the study page without altering the study data.SummaryDifference0.0%

Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.